Merit Financial Group’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$585K Buy
3,000
+771
+35% +$160K ﹤0.01% 1409
2026
Q1
$500K Sell
2,229
-118
-5% -$29.4K ﹤0.01% 1373
2025
Q4
$565K Buy
2,347
+525
+29% +$134K ﹤0.01% 1240
2025
Q3
$499K Buy
1,822
+364
+25% +$99.4K ﹤0.01% 1193
2025
Q2
$376K Sell
1,458
-77
-5% -$18.4K ﹤0.01% 1231
2025
Q1
$344K Sell
1,535
-476
-24% -$111K 0.01% 1076
2024
Q4
$460K Buy
+2,011
New +$484K 0.01% 753

Other funds holding RMD

Merit Financial Group's RMD Position: Q2 2026 in Review

Merit Financial Group increased its ResMed (RMD) stake by 35% in Q2 2026, buying an estimated $160K and bringing the position to 3,000 shares worth $585K. The position accounts for ﹤0.01% of the portfolio, ranked #1409.

Merit Financial Group first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. 154 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Merit Financial Group held 3,000 shares of ResMed worth $585K as of Q2 2026.
  • Merit Financial Group bought 771 ResMed shares in Q2 2026, an estimated $160K.
  • ResMed made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #1409 holding.
  • Merit Financial Group first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
  • 154 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.